MedPath

The Effect of a Contingency Management Intervention on Substance Use

Not Applicable
Completed
Conditions
Substance Use Disorders
Registration Number
NCT00252512
Lead Sponsor
VA Office of Research and Development
Brief Summary

Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.

Detailed Description

Design: This will be a randomized, controlled trial. 360 veterans presenting for specialty substance use disorders treatment at the Minneapolis VAMC and the VA Puget Sound Health Care System will be randomly assigned to 8 weeks of Usual Care or Usual Care plus Contingency Management. Minimal exclusion criteria include primary cannabis dependence, primary opioid dependence, screening positive for pathological gambling, serious psychiatric symptoms or suicide risk. Randomization will be stratified by site and primary substance use disorder (alcohol or stimulant). All participants will meet with a research assistant twice per week to submit urine drug and breath alcohol samples. Participants randomized to the contingency management interventions will have the opportunity to draw tokens (with replacement) from a bowl each time they submit negative urine drug and breath alcohol screens. The number of drawings allowed escalates with continuous weeks of negative screens or returns to baseline if screens are positive or missed. Half of the 500 tokens will result in social reinforcement ("Good Job!"). The remainder will earn a VA canteen voucher worth monetary value. Follow-up assessments occur 2, 6, and 12 months after enrollment into the study. Primary outcomes measures include number of days with negative urine drug and breath alcohol screens during the intervention phase, days of treatment attendance during the intervention phase, and percent days abstinent on the Timeline Follow-Back interview at follow-up assessments. Secondary outcomes include a brief assessment of employment, housing, legal, and psychiatric status, and administrative data on VA service utilization. A process evaluation and an economic analysis are included.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
332
Inclusion Criteria
  • veterans presenting for outpatient substance use disorders treatment with a diagnosis of alcohol, cocaine, amphetamine, or methamphetamine dependence
Exclusion Criteria
  • primary cannabis dependence
  • primary opioid dependence
  • severe psychiatric symptoms
  • suicide risk
  • positive history or screen for pathological gambling
  • lacking transportation or living too far away to attend twice per week research appointments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 168 weeks
Secondary Outcome Measures
NameTimeMethod
VHA Healthcare Service UtilizationBaseline to 6 month follow up and 6 month follow up to 12 month follow up.

Cost of total healthcare utilization for six month period between baseline and 6 month follow up and six month period between 6 month and 12 month follow up.

Housing8 week, 6 month and 12 month follow-ups

Number of participants reporting stable housing (owned or rented house, apartment or room)

Employment Status8 week, 6 month and 12 month follow up

Number of participants identifying themselves as unemployed.

Legal Status8 weeks, 6 month and 12 month follow ups

Number of participants reporting detention or incarceration in the previous 30 days

Psychiatric Status8 weeks, 6 months, 12 months

Kessler Psychological Distress Scale (K10) - score range 10 to 50.

* score under 20 are likely to be well

* score 20-24 are likely to have mild psychological distress

* score 25-29 are likely to have moderate psychological distress

* score 30 and over are likely to have a severe psychological distress

Trial Locations

Locations (2)

Minneapolis VA Health Care System, Minneapolis, MN

🇺🇸

Minneapolis, Minnesota, United States

VA Puget Sound Health Care System Seattle Division, Seattle, WA

🇺🇸

Seattle, Washington, United States

Minneapolis VA Health Care System, Minneapolis, MN
🇺🇸Minneapolis, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.